Abstract:Following the discovery that caloric restriction extends the lifespan of many species of animals, the free radical theory of aging attributes the occurrence of oxidized nucleic acids, proteins, and lipids to reactive oxygen radical species originating from the metabolism of foods and the diminished efficacy of oxidative metabolism. Because of the decline of many critical neuro-hormones in aging, the neuroendocrine theory of aging attributes these changes to reduced feedback control of hormone production by the hypothalamus. Several rare genetic diseases attribute accelerated aging to changes in deoxyribonucleic acid (DNA) repair, depletion of the coenzyme nicotinamide adenine dinucleotide (NAD+), and altered methionine and homocysteine metabolism. The theory of oxidative phosphorylation attributes mitochondrial adenosine triphosphate (ATP) synthesis to the active site, thioretinaco ozonide oxygen NAD+ phosphate, which couples polymerization of NAD+ and phosphate to ATP produced by reduction of oxygen by electrons derived from foods. Loss of the thioretinaco ozonide oxygen ATP complex from the opening of the mitochondrial permeability transition pore (mPTP) is proposed to explain the abnormalities of oxidative metabolism occurring in cellular aging and carcinogenesis, thereby uniting the free radical and neuroendocrine theories of aging. Cellular senescence is associated with shortening of telomeres and decreased activity of telomerase, and exposure of cultured endothelial cells to homocysteine causes cellular senescence, shortened telomeres, and increased acidic β-galactosidase, a marker of cellular senescence. The decrease in telomerase with aging is related to decreased nitric oxide production by nitric oxide synthase. The pathogenic microbes occurring in atherosclerotic plaques and in cerebral plaques in dementia inhibit nitric oxide synthesis by up-regulation of polyamine biosynthesis from adenosyl methionine and putrescene, causing the hyperhomocysteinemia and suppressed immunity that is observed in atherosclerosis and dementia. Progressive mitochondrial dysfunction occurs in aging because of loss of the thioretinaco ozonide oxygen ATP complex from mitochondrial membranes by opening of the mitochondrial permeability transition pore. Melatonin, a neuro-hormone, and cycloastragenol, a telomerase activator, both prevent mitochondrial dysfunction by inhibition of mPTP pore opening. The carcinogenic effects of radiofrequency radiation and mycotoxins are attributed to loss of thioretinaco ozonide from opening of the mPTP and decomposition of the active site of oxidative phosphorylation. The anti-aging effects of retinoids, the decreased concentration of cerebral cobalamin coenzymes in aging, and the diminished concentration of NAD+ from sirtuin activation, as observed in aging, all support the concept of loss of the thioretinaco ozonide oxygen ATP active site from mitochondria as the cause of decreased oxidative phosphorylation and mitochondrial dysfunction in aging.

Heme Deficiency Selectively Interrupts Assembly of Mitochondrial Complex Iv in Human Fibroblasts - Relevance to Aging

Role of Heme metabolism in the oxidative state of NO‐receptor soluble guanylyl cyclase (sGC) in aging mouse brain

Review: Chemical Pathology of Homocysteine VI. Aging, Cellular Senescence, and Mitochondrial Dysfunction

Advanced Age Is Associated with Iron Dyshomeostasis and Mitochondrial DNA Damage in Human Skeletal Muscle

Comprehensive investigations of key mitochondrial metabolic changes in senescent human fibroblasts

Altered Expression of Mitoferrin and Frataxin, Larger Labile Iron Pool and Greater Mitochondrial DNA Damage in the Skeletal Muscle of Older Adults

Intracellular Iron Deficiency and Abnormal Metabolism, Not Ferroptosis, Contributes to Homocysteine-Induced Vascular Endothelial Cell Death

The effect of aging and increasing ascorbate concentrations on respiratory chain activity in cultured human fibroblasts

Aging Triggers Mitochondrial Dysfunction in Mice

Oxidative Stress, Mitochondrial DNA Mutation, and Impairment of Antioxidant Enzymes in Aging 1

Mitochondrial ALDH2 deficiency promotes fibrosis and reactive oxygen species formation in the myocardium of aged mice

Age modifies respiratory complex I and protein homeostasis in a muscle type‐specific manner

Complex II defect via down-regulation of iron-sulfur subunit induces mitochondrial dysfunction and cell cycle delay in iron chelation-induced senescence-associated growth arrest

The Cellular Stability Hypothesis: Evidence of Ferroptosis and Accelerated Aging-Associated Diseases as Newly Identified Nutritional Pentadecanoic Acid (C15:0) Deficiency Syndrome

Delaying Brain Mitochondrial Decay and Aging with Mitochondrial Antioxidants and Metabolites

Iron derived from NCOA4-mediated ferritinophagy causes cellular senescence via the cGAS-STING pathway

Iron Accumulation with Age alters Metabolic Pattern and Circadian Clock gene expression through the reduction of AMP-modulated Histone Methylation

CD38 and the mitochondrial calcium uniporter contribute to age-related hematopoietic stem cell dysfunction

Hydrogen Sulfide Inhibits Ferroptosis in Cardiomyocytes to Protect Cardiac Function in Aging Rats

The Effect of Aging on Mitochondrial Complex I and the Extent of Oxidative Stress in the Rat Brain Cortex

Posttranslational modifications and dysfunction of mitochondrial enzymes in human heart failure